Vaccine-preventable diseases: From paediatric to adult targets

European Journal of Internal Medicine

Volumn 25, Issue 3, 2014, Pages 203-212

  Esposito, Susanna ^a   Durando, Paolo ^b   Bosis, Samantha ^a   Ansaldi, Filippo ^b   Tagliabue, Claudia ^a   Icardi, Giancarlo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Adults; Infectious diseases; Prevention; The elderly; Vaccination; Vaccine

Indexed keywords

CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; TYPHOID VACCINE; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

DRUG COST; GROUPS BY AGE; HEALTH CARE PERSONNEL; HUMAN; INFECTION; INFECTION PREVENTION; INFLUENZA; LANGUAGE; MEDICATION COMPLIANCE; PROFESSIONAL KNOWLEDGE; REVIEW; TRAVEL; VACCINATION; ADULT; CHILD; INFECTION CONTROL; PROCEDURES;

ADULT; CHILD; COMMUNICABLE DISEASE CONTROL; HUMANS; TRAVEL; VACCINATION; VACCINES;

EID: 84896393337     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.12.004     Document Type: Review

References (130)

1. S.L. Plotkin, and S.A. Plotkin A short history of vaccination S.A. Plotkin, W.A. Orenstein, Vaccines 4th ed. 2004 Saunders Philadelphia 1 15
2. A.R. Hinman, and W.A. Orenstein Immunisation practice in developed countries Lancet 335 1990 707 710
3. A.R. Hinman, W.A. Orenstein, and A. Schuchat Vaccine-preventable diseases, immunizations, and the Epidemic Intelligence Service Am J Epidemiol 174 2011 S16 S22
4. P. Durando, L. Sticchi, L. Sasso, and R. Gasparini Public health research literature on infectious diseases: coverage and gaps in Europe Eur J Public Health 17 2007 19 23
5. Advisory Committee on Immunization Practices, Centers for Disease Control, Prevention (CDC) Final state specific influenza vaccination coverage estimates for the 2010-11 season - United States, National Immunization Survey and Behavioral Risk Factor Surveillance System, August 2010 through May 2011 2011 US Department of Health and Human Services, CDC Atlanta, GA [Available at http://www.cdc.gov/flu/professionals/vaccination/coverage-1011estimates.htm. Last accessed 28 September 2013]
6. Advisory Committee on Immunization Practices, Centers for Disease Control, Prevention (CDC) Adult vaccination coverage reported via National Health Interview Survey (NHIS) 2011 US Department of Health and Human Services, CDC Atlanta, GA [Available at http://www.cdc.gov/vaccines/stats-surv/nhis/ default.htm. Last accessed 28 September 2013]
7. Advisory Committee on Immunization Practices, Centers for Disease Control, Prevention (CDC) Recommended adult immunization schedule - United States, 2012 2012 MMWR 61
8. CDC Tetanus and pertussis vaccination coverage rates among adults aged > 18 years - United States, 1999 and 2008 MMWR 59 2010 1302 1306
9. D.M. Kieninger-Baum, and F. Zepp Vaccination in adults Internist (Berl) 52 2011 239 249
10. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study Lancet. 349 1997 1498 1504
11. A.C. Ezeh, J. Bongaarts, and B. Mberu Global population trends and policy options Lancet 380 2012 142 148
12. European Commission Ageing report: economic and budgetary projections for the EU-27 Member States (2008-2060) 2009 Office for Official Publications of the European Communities, 2009 Luxembourg [Available at http://eur-lex.europa. eu/Notice.do?mode=dbl&lng1=en,it&lng2=bg,cs,da,de,el,en,es,et,fi,fr,hu, it,lt,lv,mt,nl,pl,pt,ro,sk,sl,sv,&val=494592:cs. Last accessed 28 September 2013]
13. M. Mistry, D. Parkin, and A. Ahmad Sasieni. Cancer incidence in the United Kingdom: projections to the year 2030 Br J Cancer 105 2011 1795 1803
14. K. Christensen, G. Doblhammer, R. Rau, and J.W. Vaupel Ageing populations: the challenges ahead Lancet 374 2009 1196 1208
15. Y. Doyle, M. McKee, B. Rechel, and E. Grundy Meeting the challenge of population ageing BMJ 339 2009 892 894
16. B. Rechel, E. Grundy, J.M. Robine, J. Cylus, J.P. Mackenbach, and C. Knai et al. Ageing in the European Union Lancet 381 2013 1312 1322
17. B.D. Gushulak, J. Weekers, and D.W. MacPherson Migrants and emerging public health issues in a globalized world: threats, risks and challenges, an evidence-based framework Emerg Health Threats J 2 2009 e10
18. C.E. Siqueira, B. Lemus, and C. Levenstein Work and health in the global economy: lessons from developing and industrialized countries on the impact of work on health New Solut 12 2002 237 262
19. H. Pham, S.A. Geraci, and M.J. Burton Adult immunizations: update on recommendations Am J Med 124 2011 698 701
20. M. Hara, K. Okada, Y. Yamaguchi, S. Uno, Y. Otsuka, and C. Shimanoe et al. Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: An open randomized controlled trial in Japan Clin Vaccine Immunol 20 2013 1799 1804
21. R. Baxter, J. Bartlett, A. Rowhani-Rahbar, B. Fireman, and N.P. Klein Effectiveness of pertussis vaccines for adolescents and adults: case-control study BMJ 347 2013 f4249
22. J.S. Spika, S. Wassilak, R. Pebody, G. Lipskaya, S. Deshevoi, and D. Guris et al. Measles and rubella in the World Health Organization European region: diversity creates challenges J Infect Dis 187 2003 S191 S197
23. P. Carrillo-Santisteve, and P.L. Lopalco Measles still spreads in Europe: who is responsible for the failure to vaccinate? Clin Microbiol Infect 18 2012 50 56
24. A. Streng, V. Grote, D. Carr, C. Hagemann, and J.G. Liese Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011 BMC Infect Dis 13 2013 303
25. Y. Jiang, A. Gauthier, M.J. Postma, L. Ribassin-Majed, N. Largeron, and X. Bresse A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus Hum Vaccin Immunother 2013 [Epub Jul 23]
26. S. Esposito, V. Montinaro, S. Bosis, C. Tagliabue, E. Baggi, and N. Principi Recommendations for the use of influenza vaccine in pediatrics Hum Vaccin Immunother 8 2012 102 106
27. J.A. Udell, R. Zawi, D.L. Bhatt, M. Keshtkar-Jahromi, F. Gaughran, and A. Phrommintikul et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis JAMA 310 2013 1711 1720
28. S. Esposito, A. Musio, and N. Principi Paediatric asthma and pneumococcal vaccination Vaccine 17 2013 5015 5019
29. D.M. Vickers, A.M. Anonychuk, P. De Wals, N. Demarteau, and C.T. Bauch Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model Vaccine 2013
30. European Commission Demography Report Available at http://ec.europa.eu/ eurostat 2010 [Last accessed 28th September 2013]
31. G. Gavazzi, and K.H. Krause Ageing and infection Lancet Infect Dis 2 2002 659 666
32. B. Weinberger, D. Herndler-Brandstetter, A. Schwanninger, D. Weiskopf, and B. Grubeck-Loebenstein Biology of immune responses to vaccines in elderly persons Clin Infect Dis 46 2008 1078 1084
33. A. Panda, A. Arjona, E. Sapey, F. Bai, E. Fikrig, and R.R. Montgomery et al. Human innate immunosenescence: causes and consequences for immunity in old age Trends Immunol 30 2009 325 333
34. A. Ademokun, Y.C. Wu, and D. Dunn-Walters The ageing B cell population: composition and function Biogerontology 11 2010 125 137
35. A.C. Shaw, S. Joshi, H. Greenwood, A. Panda, and J.M. Lord Aging of the innate immune system Curr Opin Immunol 22 2010 507 513
36. A. Agrawal, and S. Gupta Impact of aging on dendritic cell functions in humans Ageing Res Rev 10 2011 336 345
37. S. Brunner, D. Herndler-Brandstetter, B. Weinberger, and B. Grubeck-Loebenstein Persistent viral infections and immune aging Ageing Res Rev 10 2011 362 369
38. C.R. Arnold, J. Wolf, S. Brunner, D. Herndler-Brandstetter, and B. Grubeck-Loebenstein Gain and loss of T cell subsets in old age - age-related reshaping of the T cell repertoire J Clin Immunol 31 2011 137 146
39. D. Frasca, and B.B. Blomberg Aging affects human B cell responses J Clin Immunol 31 2011 430 435
40. A.S. Monto, F. Ansaldi, R. Aspinall, J.E. McElhaney, L.F. Montaño, and K.L. Nichol et al. Influenza control in the 21st century: optimizing protection of older adults Vaccine 27 2009 5043 5053
41. R. Aspinall, G. Del Giudice, R.B. Effros, B. Grubeck-Loebenstein, and S. Sambhara Challenges for vaccination in the elderly Immunol Ageing 4 2007 9 12
42. D.C. Douek, R.D. McFarland, P.H. Keiser, E.A. Gage, J.M. Massey, and B.F. Haynes et al. Changes in thymic function with age and during the treatment of HIV infection Nature 396 1998 690 695
43. D. Rivetti, T. Jefferson, R. Thomas, M. Rudin, A. Rivetti, and C. Di Pietrantonj et al. Vaccines for preventing influenza in the elderly Cochrane Database Syst Rev 19 2006 CD004876
44. P.A. Gross, A.W. Hermogenes, H.S. Sacks, J. Lau, and R.A. Levandowski The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature Ann Intern Med 123 1995 518 527
45. T. Vu, S. Farish, M. Jenkins, and H. Kelly A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community Vaccine 20 2002 1831 1836
46. T. Jefferson, D. Rivetti, A. Rivetti, M. Rudin, P.C. Di, and V. Demicheli Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review Lancet 366 2005 1165 1174
47. K.L. Nichol, J.D. Nordin, D.B. Nelson, J.P. Mullooly, and E. Hak Effectiveness of influenza vaccine in the community-dwelling elderly N Engl J Med 357 2007 1373 1381
48. K. Goodwin, C. Viboud, and L. Simonsen Antibody response to influenza vaccination in the elderly: a quantitative review Vaccine 24 2006 1159 1169
49. D.T. O'Hagan MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection Expert Rev Vaccines 6 2007 699 710
50. S. Squarcione, S. Sgricia, L.R. Biasio, and E. Perinetti Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects Vaccine 21 2003 1268 1274
51. A. Banzhoff, P. Nacci, and A. Podda A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis Gerontology 49 2003 177 184
52. R. Li, H. Fang, Y. Li, Y. Liu, M. Pellegrini, and A. Podda Safety and immunogenicity of an MF59-adjuvanted subunit influenza vaccine in elderly Chinese subjects Immun Ageing 5 2008 2
53. V. Baldo, T. Baldovin, A. Floreani, M. Minuzzo, and R. Trivello Response to influenza vaccine in people with non-protective HI antibody titers Eur J Epidemiol 21 2006 843 845
54. I.A. de Bruijn, J. Nauta, L. Gerez, and A.M. Palache Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers Virus Res 103 2004 139 145
55. I. de Bruijn, I. Meyer, L. Gerez, J. Nauta, K. Giezeman, and B. Palache Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly Vaccine 26 2007 119 127
56. J. Evison, S. Farese, M. Seitz, D.E. Uehlinger, H. Furrer, and K. Mühlemann Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients Clin Infect Dis 48 2009 1402 1412
57. I.A. de Bruijn, J. Nauta, W.C. Cramer, L. Gerez, and A.M. Palache Clinical experience with inactivated, virosomal influenza vaccine Vaccine 23 2005 S39 S49
58. A. Huckriede, L. Bungener, T. Stegmann, T. Daemen, J. Medema, and A.M. Palache et al. The virosome concept for influenza vaccines Vaccine 23 2005 S26 S38
59. C. Herzog, K. Hartmann, V. Künzi, O. Kürsteiner, R. Mischler, and H. Lazar et al. Eleven years of Inflexal V: a virosomal adjuvanted influenza vaccine Vaccine 27 2009 4381 4387
60. G. Kanra, P. Marchisio, C. Feiterna-Sperling, G. Gaedicke, H. Lazar, and P. Durrer et al. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children Pediatr Infect Dis J 23 2004 300 306
61. I.A. de Bruijn, J. Nauta, L. Gerez, and A.M. Palache The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad) in elderly subjects Vaccine 24 2006 6629 6631
62. V. Baldo, T. Menegon, C. Bonello, A. Floreani, R. Trivello Collaborative Group Comparison of three different influenza vaccines in institutionalised elderly Vaccine 19 2001 3472 3475
63. F. Pregliasco, C. Mensi, W. Serpilli, L. Speccher, P. Masella, and A. Belloni Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly Aging 13 2001 38 43
64. B.R. Ruf, K. Colberg, M. Frick, and A. Preusche Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly Infection 32 2004 191 198
65. V. Baldo, T. Baldovin, M. Pellegrini, G. Angiolelli, S. Majori, and A. Floreani et al. Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents Clin Dev Immunol 2010 2010 517198
66. R.B. Belshe, F.K. Newman, J. Cannon, C. Duane, J. Treanor, and C. Van Hoecke et al. Serum antibody responses after intradermal vaccination against influenza N Engl J Med 351 2004 2286 2294
67. D. Holland, R. Booy, F. De Looze, P. Eizenberg, J. McDonald, and J. Karrasch et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial J Infect Dis 198 2008 650 658
68. R. Arnou, G. Icardi, M. De Decker, A. Ambrozaitis, M.P. Kazek, and F. Weber et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study Vaccine 27 2009 7304 7312
69. P. Van Damme, R. Arnou, F. Kafeja, A. Fiquet, P. Richard, and S. Thomas et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study BMC Infect Dis 10 2010 134
70. J. Potter, D.J. Stott, M.A. Roberts, A.G. Elder, B. O'Donnell, and P.V. Knight et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients J Infect Dis 175 1997 1 6
71. W.F. Carman, A.G. Elder, L.A. Wallace, K. McAulay, A. Walker, and G.D. Murray et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial Lancet 355 2000 93 97
72. S.A. Moberley, J. Holden, D.P. Tatham, and R.M. Andrews Vaccines for preventing pneumococcal infection in adults Cochrane Database Syst Rev 1 2008 CD000422
73. J.A. Walters, S. Smith, P. Poole, R.H. Granger, and R. Wood-Baker et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease Cochrane Database Syst Rev 11 2010 CD001390
74. A. Melegaro, and W.J. Edmunds The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses Eur J Epidemiol 19 2004 353 363
75. T. Maruyama, O. Taguchi, M.S. Niederman, J. Morser, H. Kobayashi, and T. Kobayashi et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial BMJ 340 2010 c1004
76. A. Vila-Corcoles, E. Salsench, T. Rodriguez-Blanco, O. Ochoa-Gondar, C. de Diego, and A. Valdivieso et al. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study Vaccine 27 2009 1504 1510
77. Available at:http://www.fda.gov/downloads/BiologicsBloodVaccines/ Vaccines/ApprovedProducts/UCM201669.pdf. Last accessed 28 September 2013.
78. K. Schmader, J.W. Gnann Jr., and C.P. Watson The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine J Infect Dis 197 2008 S207 S215
79. S. Pinchinat, A.M. Cebrián-Cuenca, H. Bricout, and R.W. Johnson Similar herpes zoster incidence across Europe: results from a systematic literature review BMC Infect Dis 13 2013 170
80. B.P. Yawn, P. Saddier, P.C. Wollan, J.L. St Sauver, M.J. Kurland, and L.S. Sy A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction Mayo Clin Proc 82 2007 1341 1349
81. R.P. Insinga, R.F. Itzler, J.M. Pellissier, P. Saddier, and A.A. Nikas The incidence of herpes zoster in a United States administrative database J Gen Intern Med 20 2005 748 753
82. J. Fashner, and A.L. Bell Herpes zoster and postherpetic neuralgia: prevention and management Am Fam Physician 83 2011 1432 1437
83. C.S. Zin, L.M. Nissen, M.T. Smith, J.P. O'Callaghan, and B.J. Moore An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy CNS Drugs 22 2008 417 442
84. R.W. Johnson, G. Wasner, P. Saddier, and R. Baron Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient Drugs Aging 25 2008 991 1006
85. J.E. McElhaney Herpes zoster: a common disease that can have a devastating impact on patients' quality of life Expert Rev Vaccines 9 2010 27 30
86. European Medicines Agency Zostavax (shingles [herpes zoster] vaccine (live]): EU summary of product characteristics 2013 [Available at: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/ human/000674/WC500053462.pdf. Last accessed 28 September 2013]
87. M.N. Oxman, M.J. Levin, G.R. Johnson, K.E. Schmader, S.E. Straus, and L.D. Gelb et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2005 2271 2284
88. B. Kerzner, A.V. Murray, E. Cheng, R. Ifle, P.R. Harvey, and M. Tomlinson et al. Safety and immunogenicity profile of the concomitant administration of Zostavax and inactivated influenza vaccine in adults aged 50 and older J Am Geriatr Soc 55 2007 1499 1507
89. C.R. MacIntyre, T. Egerton, M. McCaughey, J. Parrino, B.V. Campbell, and S.C. Su et al. Concomitant administration of zoster and pneumococcal vaccines in adults ≥ 60 years old Hum Vaccin 6 2010 894 902
90. H.F. Tseng, N. Smith, L.S. Sy, and S.J. Jacobsen Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine Vaccine 29 2011 3628 3632
91. K.E. Schmader, M.J. Levin, J.W. Gnann Jr., S.A. McNeil, T. Vesikari, and R.F. Betts et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years Clin Infect Dis 54 2012 922 928
92. M.J. Levin, M.N. Oxman, J.H. Zhang, G.R. Johnson, H. Stanley, and A.R. Hayward et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine J Infect Dis 197 2008 825 835
93. A.M. Gagliardi, B.N. Gomes Silva, M.R. Torloni, and B.G. Soares Vaccines for preventing herpes zoster in older adults Cochrane Database Syst Rev 10 2012 CD008858
94. R. Harpaz, and I.R. Ortega-Sanchez Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Prevention of herpes zoster MMWR Recomm Rep 57 2008 1 30
95. P.-J. Lu, G.L. Euler, and R. Harpaz Herpes zoster vaccination among adults aged 60 years and older, in the U.S., 2008 Am J Prev Med 40 2011 e1 e6
96. H.C. Maltezou, S. Wicker, M. Borg, U. Heininger, V. Puro, and M. Theodoridou et al. Vaccination policies for health-care workers in acute health-care facilities in Europe Vaccine 29 2011 9557 9562
97. Advisory Committee on Immunization Practices, Centers for Disease Control, Prevention (CDC) Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 60 2011 1 45
98. Ministry of Health National Immunization Plan 2012-2014 Available at http://www.salute.gov.it/imgs/C-17-pubblicazioni-1721-allegato.pdf [Last accessed 24 September 2013]
99. Advisory Committee on Immunization Practices, Centers for Disease Control, Prevention (CDC) Influenza vaccination coverage among health-care personnel - United States, 2011-12 influenza season MMWR 61 2012 753 757
100. P.R. Blank, M. Schwenkglenks, and T.D. Szucs Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons BMC Public Health 8 2008 272
101. R. Steffen, and B.A. Connor Vaccines in travel health: from risk assessment to priorities J Travel Med 12 2005 26 35
102. Khuroo M. Sultan Viral hepatitis in international travellers: risks and prevention Intern J Antimicrob Agents 21 2003 143 152
103. F. Ansaldi, L. Marensi, S. Puppo, R. Rosselli, V. Turello, and G. Zoppi et al. Molecular epidemiology and case-control approaches for management of an outbreak of hepatitis A in Liguria, Italy J Prev Med Hyg 48 2007 103 108
104. J. Kumbang, S. Ejide, R.S. Tedder, and S.L. Ngui Outbreak of hepatitis A in an extended family after importation by non-immune travelers Epidemiol Infect 140 2012 1813 1820
105. R.M. Klevens, J.T. Miller, K. Iqbal, A. Thomas, E.M. Rizzo, and H. Hanson et al. The evolving epidemiology of hepatitis A in the United States: incidence and molecular epidemiology from population-based surveillance, 2005-2007 Arch Intern Med 170 2010 1811 1818
106. P. Lu, K.K. Byrd, and T.V. Murphy Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, Unites States Vaccine 31 2013 2348 2357
107. Centers for Disease Control, Prevention Typhoid immunization. Recommendation of the Immunization Practice Advisory Committee (ACIP) MMWR Recomm Resp 3 1990 1 5 [RR-10]
108. Z.A. Memish, A. Goubeaud, M. Bröker, C. Malerczyk, and A.M. Shibl Invasive meningococcal disease and travel J Infect Public Health 3 2010 143 151
109. J.P. Cramer, and A. Wildre-Smith Meningococcal disease in travelers: update on vaccine options Curr Opin Infect Dis 25 2012 507 517
110. J.E. Staples, M. Gershman, and M. Fisher Centers for Disease Control and Prevention. Yellow fever vaccine: recommendation of Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 59 2010 1 27
111. R.M. Wolfe, and L.K. Sharp Anti-vaccinationists past and present BMJ 325 2002 430 432
112. N. Principi, and S. Esposito Adolescents and vaccines in the western world Vaccine 31 2013 5366 5374
113. R.A. Brenner, B.G. Simons-Morton, B. Bhaskar, A. Das, J.D. Clemens, and NIH-DC Initiative Immunization Working Group Prevalence and predictors of immunization among inner-city infants: a birth cohort study Pediatrics 108 2001 661 670
114. Centers for Disease Control, Prevention Notice to readers: limited supply of pneumococcal conjugate vaccine: suspension of recommendations for fourth dose MMWR Morb Mortal Wkly Rep 53 2004 108 109
115. Centers for Disease Control, Prevention Notice to readers: updated recommendations on the use of pneumococcal conjugate vaccine: suspension of recommendation for third and fourth dose MMWR Morb Mortal Wkly Rep 53 2004 177 178
116. S.J. Schaffer, S.G. Humiston, L.P. Shone, F.M. Averhoff, and P.G. Szilagyi Adolescent immunization practices: a national survey of U.S. physicians Arch Pediatr Adolesc Med 155 2001 566 571
117. E.E. Kanitz, L.A. Wu, C. Giambi, R.A. Strikas, D. Levy-Bruhl, and P. Stefanoff et al. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage Vaccine 30 2012 5222 5228
118. C.D. Tierney, H. Yusuf, S.R. McMahon, D. Rusinak, M.A. O' Brien, and M.S. Massoudi et al. Adoption of reminder and recall messages for immunizations by pediatricians and public health clinics Pediatrics 112 2003 1076 1082
119. D.R. Johnson, K.L. Nichol, and K. Lipczynski Barriers to adult immunization Am J Med 121 2008 S28 S35
120. W.S. Pearson, G. Zhao, and E.S. Ford An Analysis of Language as a Barrier to Receiving Influenza Vaccinations among an Elderly Hispanic Population in the United States Adv Prev Med 2011 2011 298787
121. A. Taddio, M. Ipp, S. Thivakaran, A. Jamal, C. Parikh, and S. Smart et al. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults Vaccine 30 2012 4807 4812
122. P.R. Blank, M. Schwenkglenks, and T.D. Szucs Vaccination coverage rates in eleven European countries during two consecutive influenza seasons J Infect 58 2009 446 458
123. A.E. Fiore, T.M. Uyeki, K. Broder, L. Finelli, G.L. Euler, and J.A. Singleton et al. Prevention and Control of Influenza with Vaccines, Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 59 2010 1 62
124. M.D. Nettleman, and V. Garcia-Chen Vaccinating through a lifetime: adult priorities S D Med Spec. no 2013 73 79
125. M.S. Stockwell, E.O. Kharbanda, R.A. Martinez, C.Y. Vargas, D.K. Vawdrey, and S. Camargo Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial JAMA 307 2012 1702 1708
126. P.G. Szilagyi, C. Bordley, J.C. Vann, A. Chelminski, R.M. Kraus, P.A. Margolis, and L.E. Rodewald Effect of patient reminder/recall interventions on immunization rates: a review JAMA 284 2000 1820 1827
127. T.S. Loo, R.B. Davis, L.A. Lipsitz, J. Irish, C.K. Bates, and K. Agarwal Electronic medical record reminders and panel management to improve primary care of elderly patients Arch Intern Med 171 2011 1552 1558
128. V. Laurent-Ledru, A. Thomson, and J. Monsonego Civil society: a critical new advocate for vaccination in Europe Vaccine 29 2011 624 628
129. E. Mossialos, A. Dixon, J. Figueras, and J. Kutzin Funding health care: options for Europe European Observatory on Health Care Systems series 2002 Open University Press Buckingham, UK
130. R. Prislin, J.A. Dyer, C.H. Blakely, and C.D. Johnson Immunization status and sociodemographic characteristics: the mediating role of beliefs, attitudes, and perceived control Am J Public Health 88 1998 1821 1826